Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging
- Washington Univ. School of Medicine, St. Louis, MO (United States). Dept. of Radiology
- Pfizer Worldwide Research and Development, Cambridge, MA (United States). Worldwide Medicinal Chemistry
- Pfizer Worldwide Research and Development, Groton, CT (United States). Worldwide Medicinal Chemistry
- Pfizer Worldwide Research and Development, Cambridge, MA (United States). Pharmacokinetics, Dynamics and Metabolism
- Pfizer Worldwide Research and Development, Cambridge, MA (United States). Clinical and Translational Imaging
PURPOSE: Copper-64 (Cu-64) and Galium-68 (Ga-68) radiolabeled DO3A and NODA conjugates of exendin-4 were used for preclinical imaging of pancreatic β cells via targeting of glucagon-like peptide-1 receptor (GLP-1R). PROCEDURES: DO3A-VS- and NODA-VS-tagged Cys40exendin-4 (DO3A-VS-Cys40-exendin-4 and NODA-VS-Cys40-exendin-4, respectively) were labeled with Cu-64 and Ga-68 using standard techniques. Biodistribution and dynamic positron emission tomography (PET) were carried out in normal Sprague-Dawley (SD) rats. Ex vivo autoradiography imaging was conducted with freshly frozen pancreatic thin sections. RESULTS: DO3A-VS- and NODA-VS-Cys40-exendin-4 analogues were labeled with Cu-64 and Ga-68 to a specific activity of 518.7 ± 3.7 Ci/mmol (19.19 ± 0.14 TBq/mmol) and radiochemical yield above 98 %. Biodistribution data demonstrated pancreatic uptake of 0.11 ± 0.02 %ID/g for [64Cu]DO3A-VS-, 0.14 ± 0.02 %ID/g for [64Cu]NODA-VS-, 0.11 ± 0.03 for [68Ga]DO3A-VS-, and 0.26 ± 0.03 for [68Ga]NODA-VS-Cys40-exendin-4. Excess exendin-4 and exendin-(9-39)-amide displaced all four Cu-64 and Ga-68 labeled exendin-4 derivatives in blocking studies. CONCLUSIONS: [64Cu]/[68Ga]DO3A-VS-Cys40- and [64Cu]/[68Ga]NODA-VS-Cys40-exendin-4 can be used as PET imaging agents specific for GLP-1R expressed on β cells. Here in this paper, we report the first evidence of pancreatic uptake visualized with exendin-4 derivative in a rat animal model via in vivo dynamic PET imaging.
- Research Organization:
- The Washington Univ., St. Louis, MO (United States)
- Sponsoring Organization:
- USDOE
- Grant/Contract Number:
- SC0002032
- OSTI ID:
- 1467465
- Journal Information:
- Molecular Imaging and Biology, Vol. 18, Issue 1; ISSN 1536-1632
- Country of Publication:
- United States
- Language:
- English
Web of Science
Characterization of 5-(2-18F-fluoroethoxy)-L-tryptophan for PET imaging of the pancreas
|
journal | January 2016 |
Characterization of 5-(2-18F-fluoroethoxy)-L-tryptophan for PET imaging of the pancreas
|
journal | January 2016 |
Radiolabeled Cationic Peptides for Targeted Imaging of Infection
|
journal | October 2019 |
Radiomanganese PET Detects Changes in Functional β-Cell Mass in Mouse Models of Diabetes
|
journal | May 2017 |
Similar Records
GLP-1 receptor antagonist as a potential probe for pancreatic {beta}-cell imaging
Islet-selectivity of G-protein coupled receptor ligands evaluated for PET imaging of pancreatic {beta}-cell mass